Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Chromatin activation profiling of stereotyped chronic lymphocytic leukemias reveals a subset 8–specific signature

Maria Tsagiopoulou, Vicente Chapaprieta, Nuria Russiñol, Beatriz García-Torre, Nikolaos Pechlivanis, Ferran Nadeu, Nikos Papakonstantinou, Niki Stavroyianni, Anastasia Chatzidimitriou, Fotis Psomopoulos, Elías Campo, Kostas Stamatopoulos, José Ignacio Martín-Subero

Blood (2023) 141 (24): 2955–2960.

https://doi.org/10.1182/blood.2022016587

Published: 2023

Includes: Supplemental data

Journal Articles

Molecular and Functional Profiling of Microenvironmental Interactions in Splenic Marginal Zone Lymphoma

Blood (2022) 140 (Supplement 1): 9294–9295.

https://doi.org/10.1182/blood-2022-168728

Published: 2022

Journal Articles

Genome-Wide Histone Acetylation Profiling in Chronic Lymphocytic Leukemia Reveals a Distinctive Signature in Stereotyped Subset #8

Maria Tsagiopoulou, Vicente Chapaprieta, Nuria Russiñol, Fotis Psomopoulos, Nikos Papakonstantinou, Niki Stavroyianni, Achilles Anagnostopoulos, Panagoula Kollia, PhD, Elias Campo, Kostas Stamatopoulos, José I. Martin-Subero

Blood (2019) 134 (Supplement_1): 1241.

https://doi.org/10.1182/blood-2019-127817

Published: 2019

Journal Articles

Detailed Functional Characterization of Splenic Marginal Zone Lymphoma: Uncovering Links between the Epigenetic and the Signaling Machinery

Stavroula Ntoufa, Maria Gounari, Nikos Papakonstantinou, Despoina Binou, Ioannis Tyritidis, Theodora Stivarou, Ioannis Sarrigeorgiou, Anastasia Iatrou, Niki Stavroyianni, Achilles Anagnostopoulos, Peggy Lymberi, Kostas Stamatopoulos

Blood (2019) 134 (Supplement_1): 1512.

https://doi.org/10.1182/blood-2019-127909

Published: 2019

Journal Articles

The Transcription Factor TAp63 Exerts Pro-Survival Effects in Chronic Lymphocytic Leukemia Acting through the BCL2 Pathway

Stamatia Laidou, Stavroula Ntoufa, Sofia Papanikolaou, Konstantia Kotta, Maria Koutroumani, Theodoros Moysiadis, Achilles Anagnostopoulos, Anastasia Kouvatsi, Niki Stavroyianni, Anastasia Hadzidimitriou, PhD, Antonios M. Makris, Nikos Papakonstantinou, Kostas Stamatopoulos, MD PhD

Blood (2018) 132 (Supplement 1): 3110.

https://doi.org/10.1182/blood-2018-99-118167

Published: 2018

Journal Articles

RPS15 mutations Repress mRNA Translation in Chronic Lymphocytic Leukemia Cells

Stavroula Ntoufa, Stamatia Laidou, Fotis Psomopoulos, Marina Gerousi, Larry Mansouri, Georgios Tsiolas, Nikos Papakonstantinou, Achilles Anagnostopoulos, Niki Stavroyianni, Antonios M. Makris, Anastasia Hadzidimitriou, PhD, Richard Rosenquist, MD PhD, Kostas Stamatopoulos, MD PhD

Blood (2018) 132 (Supplement 1): 1843.

https://doi.org/10.1182/blood-2018-99-118150

Published: 2018

Journal Articles

Genome-Wide DNA Methylation Profiling of Chronic Lymphocytic Leukemia Subsets Carrying Stereotyped B Cell Receptors

Blood (2017) 130 (Supplement 1): 57.

https://doi.org/10.1182/blood.V130.Suppl_1.57.57

Published: 2017

Journal Articles

External Stimuli Modulate EZH2 Expression in Chronic Lymphocytic Leukemia. Rationale and Evidence for Synergistic Anti-Tumor Effects of B Cell Signaling and EZH2 Inhibitors

Elisavet Chartomatsidou, Stavroula Ntoufa, Konstantia Kotta, Marianna Akritidou, Theoni Trangas, Niki Stavroyianni, Achilles Anagnostopoulos, Richard Rosenquist, MD PhD, Paolo Ghia, Nikos Papakonstantinou, Kostas Stamatopoulos

Blood (2017) 130 (Supplement 1): 4295.

https://doi.org/10.1182/blood.V130.Suppl_1.4295.4295

Published: 2017

Journal Articles

Tp63 Contributes to the Apoptosis Resistant Phenotype in Aggressive Chronic Lymphocytic Leukemia

Stavroula Ntoufa, Nikos Papakonstantinou, Despoina Papazoglou, Maria Tsagiopoulou, Sarka Pospisilova, Achilles Anagnostopoulos, Richard Rosenquist, Paolo Ghia, Kostas Stamatopoulos

Blood (2015) 126 (23): 4142.

https://doi.org/10.1182/blood.V126.23.4142.4142

Published: 2015

Journal Articles

Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8

Maria Gounari, Stavroula Ntoufa, Benedetta Apollonio, Nikos Papakonstantinou, Maurilio Ponzoni, Charles C. Chu, Davide Rossi, Gianluca Gaidano, Nicholas Chiorazzi, Kostas Stamatopoulos, Paolo Ghia

Blood (2015) 125 (23): 3580–3587.

https://doi.org/10.1182/blood-2014-09-603217

Published: 2015

Includes: Supplemental data

Journal Articles

Overexpression of the Histone Methyltransferase ΕΖΗ2 in Chronic Lymphocytic Leukemia Confers Protection from Apoptosis and Is Linked to Clinical Aggressiveness

Nikos Papakonstantinou, Stavroula Ntoufa, Elisavet Chartomatsidou, Andreas Agathangelidis, Tzeni Karamanli, Achilles Anagnostopoulos, Paolo Ghia, Richard Rosenquist, Chrysoula Belessi, Kostas Stamatopoulos

Blood (2014) 124 (21): 1956.

https://doi.org/10.1182/blood.V124.21.1956.1956

Published: 2014

Journal Articles

B-Cell Anergy Underlies Indolent Clinical Behavior Of CLL Stereotyped Subset #4

Stavroula Ntoufa, Nikos Papakonstantinou, Benedetta Apollonio, Maria Gounari, Achilles Anagnostopoulos, MD, Chrysoula Belessi, Marta Muzio, Paolo Ghia, MD, PhD, Kostas Stamatopoulos

Blood (2013) 122 (21): 4115.

https://doi.org/10.1182/blood.V122.21.4115.4115

Published: 2013

Journal Articles

DNA Methylation Changes In Patients With Chronic Lymphocytic Leukemia Relapsing After Treatment Are Not Stochastic But Rather Selectively Affect Critical Pathways For B-Cell Physiology

Nikos Papakonstantinou, Andigoni Malousi, Maria Tsagiopoulou, Jana Gutwein, Ole Ammerpohl, Michael Kneba, MD, Achilles Anagnostopoulos, MD, Matthias Ritgen, MD, Nikos Maglaveras, Reiner Siebert, MD, Christiane Pott, M.D. Ph.D., Kostas Stamatopoulos

Blood (2013) 122 (21): 4146.

https://doi.org/10.1182/blood.V122.21.4146.4146

Published: 2013

Journal Articles

The Mir17∼92 Cluster Is an Immunomodulator in CLL Regulating Distinct Functional Responses to Toll-Like Receptors in Subsets with Stereotyped Antigen Receptors

Stavroula Ntoufa, Nikos Papakonstantinou, Christos Nikolaou, Elisavet Chartomatzidou, Tasoula Touloumenidou, Achilles Anagnostopoulos, Marta Muzio, Paolo Ghia, Chrysoula Belessi, Kostas Stamatopoulos

Blood (2012) 120 (21): 3862.

https://doi.org/10.1182/blood.V120.21.3862.3862

Published: 2012

Journal Articles

CLL Subsets with Distinct Stereotyped B Cell Receptors Have Distinct Epigenetic Make-up, Even Beyond IGHV Gene Mutational Status: DNA Methylation Profiling of IGHV-Unmutated CLL Stereotyped Subsets #6 and #8

Nikos Papakonstantinou, Jana Gutwein, Ole Ammerpohl, Eva Koravou, Chrysoula Belessi, Reiner Siebert, Michael Kneba, MD, PhD, Matthias Ritgen, Kostas Stamatopoulos, Christiane Pott

Blood (2012) 120 (21): 3869.

https://doi.org/10.1182/blood.V120.21.3869.3869

Published: 2012

Journal Articles

Differential Functional Outcomes After Stimulation Via Innate Immunity Receptors In Chronic Lymphocytic Leukemia Subtypes Defined by the Molecular Features of the Immunoglobulin Receptor

Stavroula Ntoufa, Anna Vardi, Nikos Papakonstantinou, Achilles Anagnostopoulos, Vassiliki Aleporou-Marinou, Federico Caligaris-Cappio, M.D., Chrysoula Belessi, Paolo Ghia, Marta Muzio, Kostas Stamatopoulos

Blood (2010) 116 (21): 374.

https://doi.org/10.1182/blood.V116.21.374.374

Published: 2010

Journal Articles

Toll-Like Receptor Signaling Pathway In Chronic Lymphocytic Leukemia: Distinct Gene Expression Profiles of Potential Pathogenetic Significance In Specific Subsets of Patients

Eleni Arvaniti, Stavroula Ntoufa, Nikos Papakonstantinou, Tasoula Touloumenidou, Nikolaos Laoutaris, Achilles Anagnostopoulos, Kleoniki Lamnisou, Federico Caligaris-Cappio, M.D., Kostas Stamatopoulos, Paolo Ghia, Marta Muzio, Chrysoula Belessi

Blood (2010) 116 (21): 44.

https://doi.org/10.1182/blood.V116.21.44.44

Published: 2010

NARROW

Chromatin activation profiling of stereotyped chronic lymphocytic leukemias reveals a subset 8–specific signature

Molecular and Functional Profiling of Microenvironmental Interactions in Splenic Marginal Zone Lymphoma

Genome-Wide Histone Acetylation Profiling in Chronic Lymphocytic Leukemia Reveals a Distinctive Signature in Stereotyped Subset #8

Detailed Functional Characterization of Splenic Marginal Zone Lymphoma: Uncovering Links between the Epigenetic and the Signaling Machinery

The Transcription Factor TAp63 Exerts Pro-Survival Effects in Chronic Lymphocytic Leukemia Acting through the BCL2 Pathway

RPS15 mutations Repress mRNA Translation in Chronic Lymphocytic Leukemia Cells

Genome-Wide DNA Methylation Profiling of Chronic Lymphocytic Leukemia Subsets Carrying Stereotyped B Cell Receptors

External Stimuli Modulate EZH2 Expression in Chronic Lymphocytic Leukemia. Rationale and Evidence for Synergistic Anti-Tumor Effects of B Cell Signaling and EZH2 Inhibitors

Tp63 Contributes to the Apoptosis Resistant Phenotype in Aggressive Chronic Lymphocytic Leukemia

Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8

Overexpression of the Histone Methyltransferase ΕΖΗ2 in Chronic Lymphocytic Leukemia Confers Protection from Apoptosis and Is Linked to Clinical Aggressiveness

B-Cell Anergy Underlies Indolent Clinical Behavior Of CLL Stereotyped Subset #4

DNA Methylation Changes In Patients With Chronic Lymphocytic Leukemia Relapsing After Treatment Are Not Stochastic But Rather Selectively Affect Critical Pathways For B-Cell Physiology

The Mir17∼92 Cluster Is an Immunomodulator in CLL Regulating Distinct Functional Responses to Toll-Like Receptors in Subsets with Stereotyped Antigen Receptors

CLL Subsets with Distinct Stereotyped B Cell Receptors Have Distinct Epigenetic Make-up, Even Beyond IGHV Gene Mutational Status: DNA Methylation Profiling of IGHV-Unmutated CLL Stereotyped Subsets #6 and #8

Differential Functional Outcomes After Stimulation Via Innate Immunity Receptors In Chronic Lymphocytic Leukemia Subtypes Defined by the Molecular Features of the Immunoglobulin Receptor

Toll-Like Receptor Signaling Pathway In Chronic Lymphocytic Leukemia: Distinct Gene Expression Profiles of Potential Pathogenetic Significance In Specific Subsets of Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only